Manulife (Manufacturers Life Insurance)’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $375K | Sell |
55,824
-648
| -1% | -$4.36K | ﹤0.01% | 2290 |
|
2025
Q1 | $511K | Sell |
56,472
-85
| -0.2% | -$768 | ﹤0.01% | 2132 |
|
2024
Q4 | $978K | Sell |
56,557
-298
| -0.5% | -$5.15K | ﹤0.01% | 1919 |
|
2024
Q3 | $909K | Sell |
56,855
-243
| -0.4% | -$3.88K | ﹤0.01% | 1971 |
|
2024
Q2 | $814K | Buy |
57,098
+2,146
| +4% | +$30.6K | ﹤0.01% | 1960 |
|
2024
Q1 | $779K | Sell |
54,952
-723
| -1% | -$10.2K | ﹤0.01% | 1987 |
|
2023
Q4 | $840K | Sell |
55,675
-474
| -0.8% | -$7.15K | ﹤0.01% | 1886 |
|
2023
Q3 | $887K | Hold |
56,149
| – | – | ﹤0.01% | 1805 |
|
2023
Q2 | $850K | Buy |
56,149
+8,437
| +18% | +$128K | ﹤0.01% | 1746 |
|
2023
Q1 | $692K | Buy |
47,712
+6,506
| +16% | +$94.3K | ﹤0.01% | 1807 |
|
2022
Q4 | $582K | Buy |
41,206
+31
| +0.1% | +$437 | ﹤0.01% | 1892 |
|
2022
Q3 | $640K | Hold |
41,175
| – | – | ﹤0.01% | 1825 |
|
2022
Q2 | $532K | Hold |
41,175
| – | – | ﹤0.01% | 2019 |
|
2022
Q1 | $393K | Buy |
+41,175
| New | +$393K | ﹤0.01% | 2341 |
|